Form 8-K - Current report:
SEC Accession No. 0001193125-25-019318
Filing Date
2025-02-03
Accepted
2025-02-03 16:39:05
Documents
13
Period of Report
2025-02-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d843857d8k.htm   iXBRL 8-K 30480
  Complete submission text file 0001193125-25-019318.txt   158005

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anro-20250203.xsd EX-101.SCH 2876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anro-20250203_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anro-20250203_pre.xml EX-101.PRE 11724
15 EXTRACTED XBRL INSTANCE DOCUMENT d843857d8k_htm.xml XML 3770
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41944 | Film No.: 25583152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)